Cargando…
Identification of serologic biomarkers for predicting microvascular invasion in hepatocellular carcinoma
Microvascular invasion (MVI) of hepatocellular carcinoma (HCC) is a major risk factor for early recurrence and poor survival after curative surgical therapies. However, MVI can only be diagnosed by pathological examination following resection. The aim of this study is to identify serologic biomarker...
Autores principales: | Yu, Yuan-Quan, Wang, Liang, Jin, Yun, Zhou, Jia-Le, Geng, Yan-Hua, Jin, Xing, Zhang, Xiao-Xiao, Yang, Jun-Jie, Qian, Cheng-Ming, Zhou, Dong-Er, Liu, Da-Ren, Peng, Shu-You, Luo, Yan, Zheng, Lei, Li, Jiang-Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941320/ https://www.ncbi.nlm.nih.gov/pubmed/26918350 http://dx.doi.org/10.18632/oncotarget.7649 |
Ejemplares similares
-
Radiomics for the detection of microvascular invasion in hepatocellular carcinoma
por: Lv, Kun, et al.
Publicado: (2022) -
Serum PON1 as a biomarker for the estimation of microvascular invasion in hepatocellular carcinoma
por: Ding, Guang-Yu, et al.
Publicado: (2020) -
Revisiting Surgical Strategies for Hepatocellular Carcinoma With Microvascular Invasion
por: Zhang, Er-lei, et al.
Publicado: (2021) -
Postoperative adjuvant therapy for hepatocellular carcinoma with microvascular invasion
por: Li, Jiang, et al.
Publicado: (2023) -
Cancer Genomic Alterations Can Be Potential Biomarkers Predicting Microvascular Invasion and Early Recurrence of Hepatocellular Carcinoma
por: Xin, Zhaodan, et al.
Publicado: (2022)